OBJECTIVE: Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. METHODS: Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neuroimaging for cerebral Aβ, APOE genotyping, and cognitive assessment as part of their baseline assessment in the Australian Imaging Biomarkers and Lifestyle study. Cognitive function was reassessed 18 months later. RESULTS: Linear mixed-model analyses adjusted for baseline cognitive function indicated that, relative to individuals with low cerebral Aβ, individuals with high cerebral Aβ showed significantly greater decline in working memory and verbal and visual episodic memory at 18 months. Compared with noncarriers, APOE ε4 carriers showed a greater decline in visual memory at the 18-month assessment. No interaction between APOE ε4 and cerebral Aβ load was observed for any measure of cognitive function. CONCLUSIONS: In this prospective study of healthy older adults, high cerebral Aβ load was associated with greater decline in episodic and working memory over 18 months. The APOE ε4 genotype was also associated with a decline in visual memory, although the effect was less than that observed for cerebral Aβ load.
OBJECTIVE: Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. METHODS: Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neuroimaging for cerebral Aβ, APOE genotyping, and cognitive assessment as part of their baseline assessment in the Australian Imaging Biomarkers and Lifestyle study. Cognitive function was reassessed 18 months later. RESULTS: Linear mixed-model analyses adjusted for baseline cognitive function indicated that, relative to individuals with low cerebral Aβ, individuals with high cerebral Aβ showed significantly greater decline in working memory and verbal and visual episodic memory at 18 months. Compared with noncarriers, APOE ε4 carriers showed a greater decline in visual memory at the 18-month assessment. No interaction between APOE ε4 and cerebral Aβ load was observed for any measure of cognitive function. CONCLUSIONS: In this prospective study of healthy older adults, high cerebral Aβ load was associated with greater decline in episodic and working memory over 18 months. The APOE ε4 genotype was also associated with a decline in visual memory, although the effect was less than that observed for cerebral Aβ load.
Authors: Michelle M Mielke; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Mary M Machulda; Davis S Knopman; Val Lowe; Rosebud O Roberts; Kejal Kantarci; Walter A Rocca; Clifford R Jack; Ronald C Petersen Journal: Alzheimers Dement Date: 2014-11-15 Impact factor: 21.566
Authors: Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger Journal: Eur J Nucl Med Mol Imaging Date: 2015-01-29 Impact factor: 9.236
Authors: Willem Huijbers; Elizabeth C Mormino; Sarah E Wigman; Andrew M Ward; Patrizia Vannini; Donald G McLaren; J Alex Becker; Aaron P Schultz; Trey Hedden; Keith A Johnson; Reisa A Sperling Journal: J Neurosci Date: 2014-04-09 Impact factor: 6.167
Authors: Yen Ying Lim; Victor L Villemagne; Simon M Laws; Robert H Pietrzak; David Ames; Christopher Fowler; Stephanie Rainey-Smith; Peter J Snyder; Pierrick Bourgeat; Ralph N Martins; Olivier Salvado; Christopher C Rowe; Colin L Masters; Paul Maruff Journal: J Mol Neurosci Date: 2016-09-01 Impact factor: 3.444
Authors: Cynthia M Stonnington; Kewei Chen; Wendy Lee; Dona E C Locke; Amylou C Dueck; Xiaofen Liu; Auttawut Roontiva; Adam S Fleisher; Richard J Caselli; Eric M Reiman Journal: Alzheimers Dement Date: 2013-04-11 Impact factor: 21.566
Authors: Ronald C Petersen; Heather J Wiste; Stephen D Weigand; Walter A Rocca; Rosebud O Roberts; Michelle M Mielke; Val J Lowe; David S Knopman; Vernon S Pankratz; Mary M Machulda; Yonas E Geda; Clifford R Jack Journal: JAMA Neurol Date: 2016-01 Impact factor: 18.302
Authors: Elizabeth C Mormino; Rebecca A Betensky; Trey Hedden; Aaron P Schultz; Andrew Ward; Willem Huijbers; Dorene M Rentz; Keith A Johnson; Reisa A Sperling Journal: Neurology Date: 2014-04-18 Impact factor: 9.910